MicroRNAs 142-3p, miR-155 and miR-203 are deregulated in gastric MALT lymphomas compared to chronic gastritis

C Fernandez, B Bellosillo, M Ferraro… - Cancer Genomics & …, 2017 - cgp.iiarjournals.org
Background: Over the last years, our knowledge on pathogenesis of gastric MALT lymphoma
has greatly improved, but its morphological diagnosis is still hampered by overlapping …

Anthracycline‐induced cardiotoxicity in diffuse large B‐cell lymphoma: NT‐proBNP and cardiovascular score for risk stratification

MP Ferraro, E Gimeno‐Vazquez… - European Journal of …, 2019 - Wiley Online Library
Objective To evaluate the role of N‐terminal pro‐brain‐type natriuretic peptide (NT‐proBNP)
and a cardiovascular (CV) risk score named FRESCO for predicting anthracycline‐induced …

[HTML][HTML] Differential impact of relative dose-intensity reductions in diffuse large B-cell lymphoma treated with R-CHOP21 or R-CHOP14

…, C Martorell, J Gines, L Garcia, E Gimeno, M Ferraro… - PloS one, 2015 - journals.plos.org
DLBCL is an aggressive lymphoma treated with R-CHOP. Recently, attempts have been
made to improve the outcome by increasing both dose-density and intensity but there have …

Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells

…, E Gimeno, S Pairet, L Camacho, M Ferraro… - Leukemia & …, 2016 - Taylor & Francis
Current standard-of-care therapy for diffuse large B-cell lymphoma (DLBCL) results in up to
40% of patients who either relapse or develop refractory disease. In this setting, further …

Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma

…, S Montesdeoca, D Román, M Ferraro… - Annals of …, 2019 - Springer
The availability of new agents for the treatment of multiple myeloma has allowed the use of
multiple lines of treatment, but a percentage of patients do not reach to receive this …

Aplastic anemia and severe myelosuppression with boceprevir or simeprevir-containing hepatitis C virus treatment

…, S Lens, N Cañete, MC Londoño, M Ferraro… - Annals of …, 2017 - medigraphic.com
The addition of the new protease inhibitors (PIs) to peg-interferon (IFN) and ribavirin (RBV),
approved for chronic hepatitis C, has clearly improved sustained virological response (SVR) …

A Risk Score for Single-Lumen Peripherally Inserted Central Catheter (PICC)-Related Venous Thrombosis in Cancer Patients Undergoing Ambulatory Chemotherapy

M Huguet, M Morgades, M Fernández, MP Ferraro… - Blood, 2022 - ashpublications.org
Introduction The extended use of peripherally inserted central catheters (PICCs) in cancer
patients have simplified the management of the treatment, but also represent an important risk …

Rituximab subcutaneous in B-cell non-Hodgkin lymphoma: clinical experience in a single center

…, E Torres, MP Ferraro Rosset… - Leukemia & …, 2018 - Taylor & Francis
Rituximab is a chimeric monoclonal antibody targeting the CD20 antigen which is present on
the surface on B-lymphocytes [1]. Rituximab has become part of the standard therapy for B-…

[HTML][HTML] Usefulness of NT-Probnp Levels and Fresco Cardiovascular Risk Scale for Prediction of Myocardiotoxicity Induced By Anthracyclines in Patients with Diffuse …

MP Ferraro, E Gimeno, M Gomez, F Garcia-Pallarols… - Blood, 2016 - Elsevier
Introduction: Anthracyclines are cytotoxic antibiotics used in the treatment of lymphomas.
Myocardiopathy is a well-known toxicity of anthracyclines, and both acute/subacute and late-…

[HTML][HTML] Evaluation of a Hepatitis B Virus Reactivation Prevention Program in Lymphoma Patients Receiving Immunochemotherapy

…, M Garcia-Retortillo, T Murcia, M Ferraro… - Blood, 2016 - Elsevier
INTRODUCTION Chemotherapy-induced hepatitis B virus (HBV) reactivation is a well-recognized
complication and is a potentially life-threatening condition in cancer patients with …